Primary Systemic Amyloidosis

Known as: Systemic Amyloidosis, amyloidosis, primary systemic, systemic amyloidosis, primary 
A plasma cell neoplasm that secretes an abnormal immunoglobulin, which deposits in various tissues and forms a beta-pleated sheet structure that… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1945-2018
05010019452017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Primary systemic amyloidosis (AL) is an incurable plasma cell disorder. Lenalidomide, especially in conjunction with… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The immunoglobulin free light chain (FLC) is the precursor protein of amyloid in primary systemic amyloidosis (AL). Historically… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Primary systemic amyloidosis (AL) is a plasma cell dyscrasia resulting in multisystem failure and death. High-dose chemotherapy… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Primary systemic amyloidosis (AL) is a fatal plasma cell disorder. Pilot data suggest survival is better in patients undergoing… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
No reports of the incidence rates for primary systemic amyloidosis (AL) have come to our attention. Records of all residents of… (More)
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Patients with primary systemic amyloidosis that affects the heart have a poor outlook. Cardiac troponins T and I (cTnT, cTnI) are… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1992
Highly Cited
1992
No reports of the incidence rates for primary systemic amyloidosis (AL) have come to our attention. Records of all residents of… (More)
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 2
Is this relevant?
1991
1991
Patients (153) with biopsy-proven primary systemic amyloidosis (AL) were evaluated for their response rate to alkylating agent… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1990
Highly Cited
1990
BACKGROUND In systemic amyloidosis the distribution and progression of disease have been difficult to monitor, because they can… (More)
Is this relevant?